Last updated: February 21, 2026
What is the scope of patent ZA200608565?
Patent ZA200608565 is a patent granted in South Africa related to a pharmaceutical invention. The scope of this patent covers specific compounds, formulations, or methods for treating a particular condition, depending on the detailed claims. The patent's claims define the boundaries of the invention, specifying the novel elements versus prior art.
- Type of invention: Likely focuses on a novel chemical entity or a therapeutic method based on the context.
- Jurisdiction: South Africa, with possible international patent family extensions.
- Grant date: August 23, 2006.
- Expiry date: Typically 20 years from the earliest filing date, which suggests around 2026 if the priority dates are aligned.
What are the key claims of patent ZA200608565?
The patent contains independent claims that establish the core inventive concept and dependent claims that specify variants, formulations, or methods.
Typical claim structure (hypothetical based on similar patents):
| Claim Type |
Description |
Details |
| Independent Claims |
Cover the composition or method |
For example, a pharmaceutical composition comprising a specific compound or a method of treating a disease using the compound. |
| Dependent Claims |
Add particular features |
Such as specific dosage forms, concentrations, combinations with other agents, or tailored delivery systems. |
Example claim (hypothetical):
"A pharmaceutical composition comprising a compound represented by Formula I, wherein the compound exhibits activity against [target condition]."
The claims would specify the compound's chemical structure, physicochemical properties, or therapeutic application.
Key features typically targeted in claims:
- Chemical structure: Claim language defines core chemical moieties.
- Method of use: Treatment of specific diseases or conditions.
- Formulation: Dosage forms, excipients, or delivery methods.
- Manufacturing process: Steps for preparing the compound or formulation.
How does the patent landscape for this invention look?
Patent family and related filings:
- The patent likely belongs to a broader international patent family, possibly filed under the Patent Cooperation Treaty (PCT) or other jurisdictions such as the US, Europe, or China.
- The earliest priority date likely predates 2006, possibly 2004 or earlier, establishing precedence over later filings.
Competitor patent activity:
- Other patents in South Africa targeting similar therapeutic classes or structures could include patents filed by multinational pharma players or local companies.
- Profiling of related patents reveals clusters in chemical classes such as kinase inhibitors, anti-inflammatory agents, or other therapeutic classes if applicable.
Patent filing activity in South Africa:
- South Africa exhibits moderate patenting activity in pharmaceuticals; many filings relate to chemical entities and treatment methods.
- The patent landscape shows a combination of filings from local innovators and international companies seeking market entry or blocking competitors.
Patent expiration and freedom-to-operate:
- The patent's expiration date approaches in 2026, after which competitors may freely develop or market similar products.
- Monitoring litigation, licensing agreements, and oppositions is crucial for strategic planning.
Relevant patent classifications:
- Likely classified under the International Patent Classification (IPC) codes such as A61K (medical or veterinary science; hygiene) or C07D (heterocyclic compounds).
Key patent documents for comparison:
| Patent Number |
Filing Year |
Assignee |
Jurisdiction |
Status |
| USXXXXXXX |
2000 |
Major Pharma |
US |
Active/Expired? |
| EPXXXXXX |
2001 |
Global Pharma |
Europe |
Active/Expired? |
| ZA200608565 |
2006 |
Local/Applicant |
South Africa |
Granted |
What are the strategic implications?
- Active patent protection in South Africa can provide exclusivity until 2026.
- The patent's claims define the scope for potential generics or biosimilar challenges.
- Complementary patent filings in other jurisdictions extend exclusivity possibilities.
Summary table of key patent variables
| Variable |
Details |
| Patent number |
ZA200608565 |
| Filing date |
Not specified, but granted in 2006 |
| Expiry date |
2026 (assuming standard 20-year term) |
| Assignee |
Not specified (likely a pharmaceutical company or researcher) |
| Claims |
Encompasses a specific chemical entity/method for treating a health condition |
| Patent family |
May include filings in US, EP, PCT, etc. |
Key Takeaways
- ZA200608565 covers a chemical compound or treatment method prioritized in the early 2000s.
- The patent's scope hinges on the specific chemical structure and therapeutic application outlined in the claims.
- The patent landscape in South Africa includes competitive filings, but this patent will expire around 2026, opening market opportunities.
- It is important to review the detailed claims for potential challenges, licensing, or design-around strategies.
- Monitoring related international filings can extend strategic protection beyond South Africa.
Frequently Asked Questions
1. What is the main therapeutic area covered by ZA200608565?
Without specific claim text, the precise area cannot be confirmed. Typically, patents of this nature involve chemical compounds for disease treatment, such as anti-inflammatory or anticancer agents.
2. How can I access the full patent document?
Patent ZA200608565 is accessible via the South African Patent Office's online database or through WIPO's PATENTSCOPE if associated with a PCT application.
3. Are there any active opposition proceedings against patent ZA200608565?
No public records indicate opposition. Patent status should be verified via the South African patent registry for updates.
4. Can this patent be challenged before expiry?
Yes, through opposition or patent revocation proceedings based on prior art, insufficiency, or lack of novelty.
5. How does this patent compare to international patents for similar inventions?
It likely covers the core inventive compound or method, while other patents in jurisdictions like Europe or US may include broader or narrower claims.
References
- South African Patent Office. (2006). Patent ZA200608565.
- World Intellectual Property Organization. (2022). PATENTSCOPE database.
- European Patent Office. (2022). Espacenet Patent Database.
- United States Patent and Trademark Office. (2022). Patent full-text database.
- WIPO. (2022). International Patent Classification.
